Who should be transplanted for AML?

被引：17

作者：

Appelbaum, FR

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA

[2] Univ Washington, Sch Med, Seattle, WA USA

来源：

LEUKEMIA | 2001年 / 15卷 / 04期

关键词：

D O I：

10.1038/sj.leu.2402074

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：680 / 682

页数：3

共 14 条

[1] Stem cell transplantation for secondary acute myeloid leukemia: Evaluation of transplantation as initial therapy or following induction chemotherapy [J].

Anderson, JE ;

Gooley, TA ;

Schoch, G ;

Anasetti, C ;

Bensinger, WI ;

Clift, RA ;

Hansen, JA ;

Sanders, JE ;

Storb, R ;

Appelbaum, FR .

BLOOD, 1997, 89 (07) :2578-2585

[2]

APPELBAUM FR, 1983, BLOOD, V61, P949

[3] BONE-MARROW TRANSPLANTS MAY CURE PATIENTS WITH ACUTE-LEUKEMIA NEVER ACHIEVING REMISSION WITH CHEMOTHERAPY [J].

BIGGS, JC ;

HOROWITZ, MM ;

GALE, RP ;

ASH, RC ;

ATKINSON, K ;

HELBIG, W ;

JACOBSEN, N ;

PHILLIPS, GL ;

RIMM, AA ;

RINGDEN, O ;

ROZMAN, C ;

SOBOCINSKI, KA ;

VEUM, JA ;

BORTIN, MM .

BLOOD, 1992, 80 (04) :1090-1093

[4] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].

Burnett, AK ;

Goldstone, AH ;

Stevens, RMF ;

Hann, IM ;

Rees, JKH ;

Gray, RG ;

Wheatley, K .

LANCET, 1998, 351 (9104) :700-708

[5] Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission [J].

Cassileth, PA ;

Harrington, DP ;

Appelbaum, FR ;

Lazarus, HM ;

Rowe, JM ;

Paietta, E ;

Willman, C ;

Hurd, DD ;

Bennett, JM ;

Blume, KG ;

Head, DR ;

Wiernik, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1649-1656

[6] ALLOGENEIC MARROW TRANSPLANTATION DURING UNTREATED 1ST RELAPSE OF ACUTE MYELOID-LEUKEMIA [J].

CLIFT, RA ;

BUCKNER, CD ;

APPELBAUM, FR ;

SCHOCH, G ;

PETERSEN, FB ;

BENSINGER, WI ;

SANDERS, J ;

SULLIVAN, KM ;

STORB, R ;

SINGER, J ;

HANSEN, JA ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1723-1729

[7] A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [J].

Estey, E ;

Kornblau, S ;

Pierce, S ;

Kantarjian, H ;

Beran, M ;

Keating, M .

BLOOD, 1996, 88 (02) :756-756

[8]

Gorin NC, 1996, BONE MARROW TRANSPL, V18, P111

[9]

Harousseau JL, 1997, BLOOD, V90, P2978

[10] DEVELOPMENT OF A MARROW TRANSPLANT REGIMEN FOR ACUTE-LEUKEMIA USING TARGETED HEMATOPOIETIC IRRADIATION DELIVERED BY I-131-LABELED ANTI-CD45 ANTIBODY, COMBINED WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION [J].

MATTHEWS, DC ;

APPELBAUM, FR ;

EARY, JF ;

FISHER, DR ;

DURACK, LD ;

BUSH, SA ;

HUI, TE ;

MARTIN, PJ ;

MITCHELL, D ;

PRESS, OW ;

BADGER, CC ;

STORB, R ;

NELP, WB ;

BERNSTEIN, ID .

BLOOD, 1995, 85 (04) :1122-1131

← 1 2 →